Matches in Wikidata for { <http://www.wikidata.org/entity/Q94408668> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q94408668 description "article by Ryo Nishikawa et al published 6 November 2017 in Neuro-Oncology" @default.
- Q94408668 description "article scientifique publié en 2017" @default.
- Q94408668 description "wetenschappelijk artikel" @default.
- Q94408668 description "наукова стаття" @default.
- Q94408668 name "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS" @default.
- Q94408668 name "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS" @default.
- Q94408668 type Item @default.
- Q94408668 label "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS" @default.
- Q94408668 label "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS" @default.
- Q94408668 prefLabel "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS" @default.
- Q94408668 prefLabel "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS" @default.
- Q94408668 P1433 Q94408668-3041145A-04C2-492C-BD56-FEAB173D2733 @default.
- Q94408668 P1476 Q94408668-9DB480F4-F898-4A8F-9B97-0CDF2A5EA1F1 @default.
- Q94408668 P2093 Q94408668-6015B500-9927-4368-9B0F-83C632C203E5 @default.
- Q94408668 P2093 Q94408668-772EB36A-9B78-42A9-835F-2A1FE61B1CF7 @default.
- Q94408668 P2093 Q94408668-97A97DB9-01A5-446B-AA58-2D0379CA1DC9 @default.
- Q94408668 P2093 Q94408668-D0965FE0-0C74-4F29-9D3B-E836943EDA6F @default.
- Q94408668 P2093 Q94408668-E23CFE3E-B124-4861-84A2-7B52096D5694 @default.
- Q94408668 P304 Q94408668-CFBD6FF5-C968-4A12-8E30-980C8E68D234 @default.
- Q94408668 P31 Q94408668-986B1315-149A-4353-AD13-ED5D0B1F1284 @default.
- Q94408668 P356 Q94408668-DF8A562F-8D05-4F37-84A8-EA7651C7A792 @default.
- Q94408668 P433 Q94408668-1588A4D5-EC1E-46C7-87AD-39B13CC1845A @default.
- Q94408668 P478 Q94408668-4C4F283E-6A9F-4452-A3FE-2ED6F2E614D0 @default.
- Q94408668 P577 Q94408668-637D60F9-96C6-45FD-BC9D-A4D914D05FD8 @default.
- Q94408668 P921 Q94408668-F3232FAC-75CC-46F9-97B5-7862040C7558 @default.
- Q94408668 P932 Q94408668-7A30D662-9595-4D69-9A85-11E0589A54D7 @default.
- Q94408668 P356 NOX168.029 @default.
- Q94408668 P1433 Q15724471 @default.
- Q94408668 P1476 "ACTR-38. SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS" @default.
- Q94408668 P2093 "Ayaka Shimizu" @default.
- Q94408668 P2093 "Masako Ura" @default.
- Q94408668 P2093 "Motoo Nagane" @default.
- Q94408668 P2093 "Ryo Nishikawa" @default.
- Q94408668 P2093 "Takashi Tamura" @default.
- Q94408668 P304 "vi8-vi8" @default.
- Q94408668 P31 Q13442814 @default.
- Q94408668 P356 "10.1093/NEUONC/NOX168.029" @default.
- Q94408668 P433 "Suppl 6" @default.
- Q94408668 P478 "19" @default.
- Q94408668 P577 "2017-11-06T00:00:00Z" @default.
- Q94408668 P921 Q413299 @default.
- Q94408668 P932 "5692943" @default.